Cite
Palonosetron, aprepitant, and dexamethasone for prevention of nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: A phase II study.
MLA
Isoda, Atsushi, et al. “Palonosetron, Aprepitant, and Dexamethasone for Prevention of Nausea and Vomiting after High-Dose Melphalan in Autologous Transplantation for Multiple Myeloma: A Phase II Study.” International Journal of Hematology, vol. 105, no. 4, Apr. 2017, pp. 478–84. EBSCOhost, https://doi.org/10.1007/s12185-016-2152-6.
APA
Isoda, A., Saito, R., Komatsu, F., Negishi, Y., Oosawa, N., Ishikawa, T., Miyazawa, Y., Matsumoto, M., Sawamura, M., & Manaka, A. (2017). Palonosetron, aprepitant, and dexamethasone for prevention of nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: A phase II study. International Journal of Hematology, 105(4), 478–484. https://doi.org/10.1007/s12185-016-2152-6
Chicago
Isoda, Atsushi, Rie Saito, Fuminori Komatsu, Yuki Negishi, Noriyasu Oosawa, Tetsuya Ishikawa, Yuri Miyazawa, Morio Matsumoto, Morio Sawamura, and Akihiro Manaka. 2017. “Palonosetron, Aprepitant, and Dexamethasone for Prevention of Nausea and Vomiting after High-Dose Melphalan in Autologous Transplantation for Multiple Myeloma: A Phase II Study.” International Journal of Hematology 105 (4): 478–84. doi:10.1007/s12185-016-2152-6.